Precision Digestive Medicine

Functional Medicine for IBS, SIBO & Chronic Digestive Disorders

For professionals and individuals experiencing persistent bloating, altered bowel habits, abdominal discomfort or microbiome dysfunction that has not resolved through conventional care.

 

Redefining Digestive Health Through Precision Functional Medicine

 

Dr. Alain Frabotta practices Precision Digestive Medicine in Sydney. He brings over 25 years of clinical experience and now focuses primarily on complex digestive and microbiome-related disorders, using a structured functional medicine framework.

His methodology integrates advanced functional diagnostics, systems-based clinical reasoning, and evidence-informed nutritional and lifestyle therapeutics to identify the underlying biological drivers of dysfunction — whether microbial imbalance, intestinal permeability, inflammatory signalling, or gut–brain axis disruption.

The objective is not symptom suppression, but restoration of digestive integrity and physiological resilience.

Recognising that each case presents with distinct clinical patterns requiring individualised assessment, his structured functional medicine approach focuses on identifying the root cause to achieve sustainable, long-term results.

His structured functional medicine framework provides in-depth assessments that go beyond conventional care, offering therapeutic strategies to help you achieve lasting improvements.

Request a Brief Introductory Consultation

THE PRECISION APPROACH

A Structured Digestive Framework

Digestive dysfunction is rarely random. It reflects converging biological stressors—microbial imbalance, altered motility patterns, immune activation, stress physiology, and post-infectious changes—interacting within the gut–brain–immune axis.

Dr. Alain Frabotta implements a staged functional medicine approach that identifies and targets the primary pathophysiological drivers of digestive disease. This includes:

Phase 1 – Clinical Mapping: Comprehensive history, symptom pattern analysis, and targeted diagnostic assessment.

Phase 2 – Targeted Intervention: Structured therapeutic strategy addressing microbial, inflammatory and functional drivers.

Phase 3 – Stabilisation: Consolidation of improvements and reduction of relapse risk.

Phase 4 – Resilience & Maintenance: Long-term digestive stability planning.